Pfizer’s Covid Windfall Shrinks, Expands Cost-Cutting Efforts

Pfizer beats Q1 EPS estimates, maintains 2025 guidance, and targets $5.7 billion in cost savings through automation and R&D streamlining.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *